{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:36:54Z","timestamp":1790757414279,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2978,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.fertnstert.2014.01.003","type":"journal-article","created":{"date-parts":[[2014,2,15]],"date-time":"2014-02-15T16:45:56Z","timestamp":1392482756000},"page":"1129-1134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features"],"prefix":"10.1016","volume":"101","author":[{"given":"Molly","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanade","family":"Shinkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Pasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Kuzmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelle","family":"Cedars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Huddleston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2014.01.003_bib1","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib2","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib3","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib4","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM\u2013Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00128071-200708040-00003","article-title":"Dermatologic manifestations of polycystic ovary syndrome","volume":"8","author":"Lee","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1529-8019.2008.00214.x","article-title":"Androgens and hair growth","volume":"21","author":"Randall","year":"2008","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaad.2004.04.008","article-title":"Evaluation and treatment of male and female pattern hair loss","volume":"52","author":"Olsen","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0303-7207(02)00372-6","article-title":"Androgens and alopecia","volume":"198","author":"Kaufman","year":"2002","journal-title":"Mol Cel Endocr"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib11","first-page":"541","article-title":"Female pattern alopecia: current perspectives","volume":"5","author":"Emer","year":"2013","journal-title":"Int J\u00a0Women\u2019s Health"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib12","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1590\/S0365-05962012000600010","article-title":"Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata","volume":"87","author":"Werner","year":"2012","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/00016340903353284","article-title":"Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism","volume":"89","author":"Ozdemir","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00404-006-0173-8","article-title":"Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam\u2019s criteria and women whose only clinical signs are oligo\/anovulation or hirsutism","volume":"274","author":"Hassa","year":"2006","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1490439","article-title":"Prevalence of polycystic ovaries in women with androgenic alopecia","volume":"149","author":"Cela","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s004030000184","article-title":"Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism","volume":"292","author":"Vexiau","year":"2000","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0190-9622(88)70241-8","article-title":"The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia","volume":"19","author":"Futterweit","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000293166","article-title":"Hormone studies in females with androgenic hair loss","volume":"31","author":"Schmidt","year":"1991","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.det.2010.03.011","article-title":"Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss","volume":"28","author":"Rathnayake","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(02)04551-X","article-title":"Treatment of hyperandrogenic alopecia in women","volume":"79","author":"Carmina","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/09546639809160698","article-title":"The Leeds revised acne grading system","volume":"9","author":"O\u2019Brien","year":"1998","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib26","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","article-title":"Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism","volume":"26","author":"Ascaso","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib27","series-title":"BDI\u2013Fast Screen for medical patients: manual","author":"Beck","year":"2000"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Utility, limitations and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib29","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/humrep\/del175","article-title":"Low sex hormone\u2013binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS","volume":"21","author":"Chen","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00043798-200306000-00012","article-title":"Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study","volume":"10","author":"Matilainen","year":"2003","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib31","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/humrep\/der071","article-title":"Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression?","volume":"26","author":"Deeks","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib32","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1093\/humrep\/der338","article-title":"Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome","volume":"26","author":"Cinar","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2265.2011.04122.x","article-title":"Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome","volume":"75","author":"Livadas","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40257-013-0010-3","article-title":"Health status, coping strategies and alexithymia in subjects with androgenic alopecia","volume":"14","author":"Tabolli","year":"2013","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib35","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-0960.2011.00745.x","article-title":"Role of genetics and sex steroid hormones in male androgenic alopecia and female pattern hair loss: an update of what we now know","volume":"52","author":"Yip","year":"2011","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.fertnstert.2014.01.003_bib37","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1439-0353.2004.04037.x","article-title":"Estrogens and the hair follicle","volume":"2","author":"Conrad","year":"2004","journal-title":"Dtsch Dermatol Ges"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214000338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214000338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:09:45Z","timestamp":1758010185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028214000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0015028214000338"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.01.003","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.01.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}